306 related articles for article (PubMed ID: 16894037)
1. Adiponectin and coronary heart disease: a prospective study and meta-analysis.
Sattar N; Wannamethee G; Sarwar N; Tchernova J; Cherry L; Wallace AM; Danesh J; Whincup PH
Circulation; 2006 Aug; 114(7):623-9. PubMed ID: 16894037
[TBL] [Abstract][Full Text] [Related]
2. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study.
Luc G; Empana JP; Morange P; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Evans A; Kee F; Bingham A; Machez E; Ducimetiere P
Int J Obes (Lond); 2010 Jan; 34(1):118-26. PubMed ID: 19823188
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.
Rothenbacher D; Brenner H; März W; Koenig W
Eur Heart J; 2005 Aug; 26(16):1640-6. PubMed ID: 15932907
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
Danesh J; Wheeler JG; Hirschfield GM; Eda S; Eiriksdottir G; Rumley A; Lowe GD; Pepys MB; Gudnason V
N Engl J Med; 2004 Apr; 350(14):1387-97. PubMed ID: 15070788
[TBL] [Abstract][Full Text] [Related]
5. Serum alanine aminotransferase is associated with serum adiponectin, C-reactive protein and apolipoprotein B in young healthy men.
Kazumi T; Kawaguchi A; Hirano T; Yoshino G
Horm Metab Res; 2006 Feb; 38(2):119-24. PubMed ID: 16523413
[TBL] [Abstract][Full Text] [Related]
6. Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease.
Shai I; Pischon T; Hu FB; Ascherio A; Rifai N; Rimm EB
Obesity (Silver Spring); 2006 Nov; 14(11):2099-106. PubMed ID: 17135628
[TBL] [Abstract][Full Text] [Related]
7. Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men.
Welsh P; Whincup PH; Papacosta O; Wannamethee SG; Lennon L; Thomson A; Rumley A; Lowe GD
QJM; 2008 Oct; 101(10):785-91. PubMed ID: 18676684
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis.
Lowe GD; Danesh J; Lewington S; Walker M; Lennon L; Thomson A; Rumley A; Whincup PH
Eur Heart J; 2004 Feb; 25(3):252-9. PubMed ID: 14972427
[TBL] [Abstract][Full Text] [Related]
9. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
Empana JP; Sykes DH; Luc G; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Bingham A; Montaye M; Ruidavets JB; Haas B; Evans A; Jouven X; Ducimetiere P;
Circulation; 2005 May; 111(18):2299-305. PubMed ID: 15867179
[TBL] [Abstract][Full Text] [Related]
10. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses.
Hashimoto N; Kanda J; Nakamura T; Horie A; Kurosawa H; Hashimoto T; Sato K; Kushida S; Suzuki M; Yano S; Iwai R; Takahashi H; Yoshida S
Metabolism; 2006 Dec; 55(12):1653-7. PubMed ID: 17142139
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study.
Yudkin JS; May M; Elwood P; Yarnell JW; Greenwood R; Davey Smith G;
Diabetologia; 2002 Mar; 45(3):327-36. PubMed ID: 11914737
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women.
Pischon T; Pai JK; Manson JE; Hu FB; Rexrode KM; Hunter D; Rimm EB
Obesity (Silver Spring); 2007 Aug; 15(8):2051-60. PubMed ID: 17712123
[TBL] [Abstract][Full Text] [Related]
13. Plasma adiponectin: a predictor of coronary heart disease in hemodialysis patients--a Japanese prospective eight-year study.
Takemoto F; Katori H; Sawa N; Hoshino J; Suwabe T; Nakanishi S; Arai S; Fukuda S; Kodaka K; Shimada M; Yamazaki C; Yokoyama K; Nakano Y; Funahashi T; Ubara Y; Yamada A; Takaichi K; Uchida S
Nephron Clin Pract; 2009; 111(1):c12-20. PubMed ID: 19052467
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany.
Koenig W; Khuseyinova N; Baumert J; Meisinger C; Löwel H
J Am Coll Cardiol; 2006 Oct; 48(7):1369-77. PubMed ID: 17010797
[TBL] [Abstract][Full Text] [Related]
15. Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies.
Sarwar N; Sattar N; Gudnason V; Danesh J
Eur Heart J; 2007 Oct; 28(20):2491-7. PubMed ID: 17513304
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
Sattar N; Murray HM; McConnachie A; Blauw GJ; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Murphy MB; Packard CJ; Perry IJ; Stott DJ; Sweeney BJ; Twomey C; Westendorp RG; Shepherd J;
Circulation; 2007 Feb; 115(8):981-9. PubMed ID: 17283264
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin represents an independent risk factor for hypertension in middle aged Korean women.
Lee HS; Lee M; Joung H
Asia Pac J Clin Nutr; 2007; 16(1):10-5. PubMed ID: 17215175
[TBL] [Abstract][Full Text] [Related]
18. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies.
Thompson A; Danesh J
J Intern Med; 2006 May; 259(5):481-92. PubMed ID: 16629854
[TBL] [Abstract][Full Text] [Related]
19. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
20. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
Tsai WC; Lin CC; Chen JY; Huang YY; Lee CH; Li WT; Weng CM; Chen JH
Blood Press; 2008; 17(4):233-8. PubMed ID: 18671144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
